-
2
-
-
84878664789
-
-
MacLaren, Robert. Gene therapy. Nuffield Laboratory of Ophthalmology. [21.07.12].
-
MacLaren, Robert. Gene therapy. Nuffield Laboratory of Ophthalmology. [21.07.12]. http://www.eye.ox.ac.uk.
-
-
-
-
3
-
-
84878663388
-
-
Institute, National Cancer. Gene therapy for cancer: questions and answers. [25.07.12].
-
Institute, National Cancer. Gene therapy for cancer: questions and answers. [25.07.12]. http://www.cancer.gov.
-
-
-
-
4
-
-
84878628444
-
-
Mandal, Ananya. Retinitis pigmentosa genetics. News Medical. [21.07.12].
-
Mandal, Ananya. Retinitis pigmentosa genetics. News Medical. [21.07.12]. http://www.news-medical.net.
-
-
-
-
6
-
-
84878664202
-
-
Retinitis pigmentosa news and research. News medical. [12.07.12].
-
Retinitis pigmentosa news and research. News medical. [12.07.12]. http://www.news-medical.net.
-
-
-
-
9
-
-
84878633219
-
-
What is gene therapy? News medical. [15.07.12].
-
What is gene therapy? News medical. [15.07.12]. http://www.news-medical.net.
-
-
-
-
10
-
-
84878633238
-
Clinical features of autosomal dominant retinitis pigmentosa associated
-
Chen Haoyu, Chen Yali, Horn Rachael, Yang Zhenglin, Wang Changguan, et al. Clinical features of autosomal dominant retinitis pigmentosa associated. Ann Acad Med 2006, 35(6):412-415.
-
(2006)
Ann Acad Med
, vol.35
, Issue.6
, pp. 412-415
-
-
Chen, H.1
Chen, Y.2
Horn, R.3
Yang, Z.4
Wang, C.5
-
11
-
-
84878665763
-
-
Canine study puts gene therapy for X-linked retinitis pigmentosa in sight. National Eye Institute. [28.06.12].
-
Hays, Dustin C. Canine study puts gene therapy for X-linked retinitis pigmentosa in sight. National Eye Institute. [28.06.12]. http://www.nei.nih.gov.
-
-
-
Hays, D.C.1
-
12
-
-
84878655317
-
-
Gene therapy first for poor sight. Stargardt's Australia. [26.06.12].
-
Ghosh, Pallab. Gene therapy first for poor sight. Stargardt's Australia. [26.06.12]. http://www.stargardts-au.org.
-
-
-
Ghosh, P.1
-
13
-
-
66149105139
-
AAV-mediated gene therapy for retinal disorders in large animal models
-
Rolling Fabienne, Moullier Philippe, Lhériteau Elsa, Stieger Knut AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J. 2009, 50(2):206-224.
-
(2009)
ILAR J.
, vol.50
, Issue.2
, pp. 206-224
-
-
Rolling, F.1
Moullier, P.2
Lhériteau, E.3
Stieger, K.4
-
14
-
-
77649242176
-
Gene therapy for Leber's Congenital Amaurosis is safe and effective through 1.5 years after vector administration
-
Simonelli F., Maguire A.M., Testa F., Pierce E.A., Mingozzi F., Bennicelli J.L. Gene therapy for Leber's Congenital Amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010, 18(3):643-650.
-
(2010)
Mol Ther
, vol.18
, Issue.3
, pp. 643-650
-
-
Simonelli, F.1
Maguire, A.M.2
Testa, F.3
Pierce, E.A.4
Mingozzi, F.5
Bennicelli, J.L.6
-
16
-
-
79960139512
-
AAV-mediated photoreceptor transduction of the pig cone-enriched retina
-
Mussolino C., Della Corte M., Rossi S., Viola F., Di Vicino U., Marrocc E. AAV-mediated photoreceptor transduction of the pig cone-enriched retina. Gene Ther 2011, 18(7):637-645.
-
(2011)
Gene Ther
, vol.18
, Issue.7
, pp. 637-645
-
-
Mussolino, C.1
Della Corte, M.2
Rossi, S.3
Viola, F.4
Di Vicino, U.5
Marrocc, E.6
-
17
-
-
65449139573
-
RPE65: role in the visual cycle, human retinal disease, and gene therapy
-
Cai X., Conley S.M., Naash M.I. RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet 2009, 30(2):57.
-
(2009)
Ophthalmic Genet
, vol.30
, Issue.2
, pp. 57
-
-
Cai, X.1
Conley, S.M.2
Naash, M.I.3
-
19
-
-
84878666090
-
-
Stargardt disease. MD support. [28.07.12].
-
Hammer R., Stargardt disease. MD support. [28.07.12]. http://www.mdsupport.org.
-
-
-
Hammer, R.1
-
20
-
-
84878664610
-
-
Nonviral DNA nanoparticles for ocular gene therapy to treat Stargardt's disease. SciBX 5(34); doi:10.1038/scibx.2012.911. Aug. 30
-
Nonviral DNA nanoparticles for ocular gene therapy to treat Stargardt's disease. SciBX 5(34); doi:10.1038/scibx.2012.911. Aug. 30 2012.
-
(2012)
-
-
-
21
-
-
84878655217
-
-
Naash, Muna. Nanoparticle-based gene therapy preserves vision in lab study for Stargardt disease. Foundation Fighting Blindness. Web: [22.07.12].
-
Naash, Muna. Nanoparticle-based gene therapy preserves vision in lab study for Stargardt disease. Foundation Fighting Blindness. Web: [22.07.12]. http://www.blindness.org.
-
-
-
-
22
-
-
57449098228
-
Magnetic nanoparticles for gene and drug delivery
-
Dobson Jon, Yiu Humphrey H.P., McBain Stuart C. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008, 3(2):169-180.
-
(2008)
Int J Nanomedicine
, vol.3
, Issue.2
, pp. 169-180
-
-
Dobson, J.1
Yiu, H.H.P.2
McBain, S.C.3
-
23
-
-
84878649169
-
Northwest science and technology. Gene therapy treats red-green colorblindness in adult monkeys
-
Berezow A.B. Northwest science and technology. Gene therapy treats red-green colorblindness in adult monkeys. Spring 2010.
-
(2010)
Spring
-
-
Berezow, A.B.1
-
25
-
-
74849104278
-
RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma
-
Li M., Xu J., Chen X., Sun X. RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma. Diagn Pathol 2009, 4(46):4-46.
-
(2009)
Diagn Pathol
, vol.4
, Issue.46
, pp. 4-46
-
-
Li, M.1
Xu, J.2
Chen, X.3
Sun, X.4
|